Clinical Trial Update: AMG 701 Expanded Access Program

View source ↗

Summary

The AMG 701 expanded access program has ended and is no longer available to patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• AMG 701

Snippet

Sponsor: Amgen | Status: NO_LONGER_AVAILABLE